Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mireia Pérez-Verdaguer, Jesusa Capera, Clara Serrano-Novillo, Irene Estadella, Daniel Sastre & Antonio Felipe. (2016) The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies. Expert Opinion on Therapeutic Targets 20:5, pages 577-591.
Read now
Read now
Neil A Castle. (2010) Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy. Expert Opinion on Therapeutic Patents 20:11, pages 1471-1503.
Read now
Read now
Articles from other publishers (66)
Jesusa Capera, Ashwin Jainarayanan, María Navarro-Pérez, Salvatore Valvo, Philippos Demetriou, David Depoil, Irene Estadella, Audun Kvalvaag, James H. Felce, Antonio Felipe & Michael L. Dustin. (2023) Dynamics and spatial organization of Kv1.3 at the immunological synapse of human CD4+ T cells. Biophysical Journal.
Crossref
Crossref
Julia Serna, Diego A. Peraza, Sara Moreno‐Estar, Juan J. Saez, Dino Gobelli, Maria Simarro, Claire Hivroz, José R. López‐López, Pilar Cidad, Miguel A. de la Fuente & M. Teresa Pérez‐García. (2023) Characterization of endogenous Kv1.3 channel isoforms in T cells. Journal of Cellular Physiology 238:5, pages 976-991.
Crossref
Crossref
Jessica Matos Kleiz-Ferreira, Hans Bernaerts, Ernesto Lopes Pinheiro-Junior, Steve Peigneur, Russolina Benedeta Zingali & Jan Tytgat. (2022) Pharmacological Screening of Venoms from Five Brazilian Micrurus Species on Different Ion Channels. International Journal of Molecular Sciences 23:14, pages 7714.
Crossref
Crossref
Elisabetta Tosti, Raffaele Boni & Alessandra Gallo. (2022) Pathophysiological Responses to Conotoxin Modulation of Voltage-Gated Ion Currents. Marine Drugs 20:5, pages 282.
Crossref
Crossref
Rikki Chokshi, Orville Bennett, Tetyana Zhelay & J. Ashot Kozak. (2021) NSAIDs Naproxen, Ibuprofen, Salicylate, and Aspirin Inhibit TRPM7 Channels by Cytosolic Acidification. Frontiers in Physiology 12.
Crossref
Crossref
Špela Gubič, Louise A. Hendrickx, Žan Toplak, Maša Sterle, Steve Peigneur, Tihomir Tomašič, Luis A. Pardo, Jan Tytgat, Anamarija Zega & Lucija P. Mašič. (2021)
Discovery of K
V
1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges
. Medicinal Research Reviews 41:4, pages 2423-2473.
Crossref
Crossref
Supriya RameshaSruti Rayaprolu, Christine A. Bowen, Cynthia R. GiverSara Bitarafan, Hai M. NguyenTianwen GaoMichael J. Chen, Ngozi Nwabueze, Eric B. Dammer, Amanda K. Engstrom, Hailian XiaoAndrea Pennati, Nicholas T. SeyfriedDavid J. Katz, Jacques Galipeau, Heike Wulff, Edmund K. Waller, Levi B. Wood, Allan I. Levey & Srikant Rangaraju. (2021) Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease. Proceedings of the National Academy of Sciences 118:11.
Crossref
Crossref
Alistair Mathie, Emma L. Veale, Alessia Golluscio, Robyn G. Holden & Yvonne Walsh. 2021. Pharmacology of Potassium Channels. Pharmacology of Potassium Channels
83
111
.
Azer Farah, Maria Kabbage, Salsabil Atafi, Amira Jaballah Gabteni, Mouadh Barbirou, Mouna Madhioub, Lamine Hamzaoui, Mousadak Azzouz Mohamed, Hassen Touinsi, Asma Ouakaa Kchaou, Emna Chelbi, Samir Boubaker, Rahma Ben Abderrazek & Balkiss Bouhaouala-Zahar. (2020) Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma. BMC Cancer 20:1.
Crossref
Crossref
Irina Gladkikh, Steve Peigneur, Oksana Sintsova, Ernesto Lopes Pinheiro-Junior, Anna Klimovich, Alexander Menshov, Anatoly Kalinovsky, Marina Isaeva, Margarita Monastyrnaya, Emma Kozlovskaya, Jan Tytgat & Elena Leychenko. (2020) Kunitz-Type Peptides from the Sea Anemone Heteractis crispa Demonstrate Potassium Channel Blocking and Anti-Inflammatory Activities. Biomedicines 8:11, pages 473.
Crossref
Crossref
Gabor Tajti, Dorothy C.C. Wai, Gyorgy Panyi & Raymond S. Norton. (2020) The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides. Biochemical Pharmacology 181, pages 114146.
Crossref
Crossref
Xiaoli Wang, Guoyi Li, Jingkang Guo, Zhiping Zhang, Shuzhang Zhang, Yudan Zhu, Jiwei Cheng, Lu Yu, Yonghua Ji & Jie Tao. (2020) Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond. Frontiers in Neuroscience 13.
Crossref
Crossref
Tengpeng Hu, Thorbjørn Krejsgaard, Claudia Nastasi, Terkild Brink Buus, Anneline Nansen, Andreas Hald, Pieter Spee, Pia Rude Nielsen, Edda Blümel, Maria Gluud, Andreas Willerslev-Olsen, Anders Woetmann, Michael Bzorek, Jens O. Eriksen, Niels Ødum & Lise Mette Rahbek Gjerdrum. (2020) Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis. Dermatology 236:2, pages 123-132.
Crossref
Crossref
Tianwen Gao, Syed Ali Raza, Supriya Ramesha, Ngozi V. Nwabueze, Amelia J. Tomkins, Lihong Cheng, Hailian Xiao, Manuel Yepes & Srikant Rangaraju. (2019) Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic stroke. Journal of Neuroinflammation 16:1.
Crossref
Crossref
Tengpeng Hu, Terkild Brink Buus, Thorbjørn Krejsgaard, Anneline Nansen, Betina Kerstin Lundholt, Pieter Spee, Simon Fredholm, David Leander Petersen, Edda Blümel, Maria Gluud, Madalena N. Monteiro, Andreas Willerslev-Olsen, Mads Hald Andersen, Per thor Straten, Özcan Met, Veronica Stolearenco, Hanne Fogh, Robert Gniadecki, Claudia Nastasi, Thomas Litman, Anders Woetmann, Lise Mette Rahbek Gjerdrum & Niels Ødum. (2019) Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome. Oncotarget 10:47, pages 4894-4906.
Crossref
Crossref
Qiwen Liao, Yu Feng, Binrui Yang & Simon Ming-Yuen Lee. (2019) Cnidarian peptide neurotoxins: a new source of various ion channel modulators or blockers against central nervous systems disease. Drug Discovery Today 24:1, pages 189-197.
Crossref
Crossref
Srikant Rangaraju, Eric B. Dammer, Syed Ali Raza, Priyadharshini Rathakrishnan, Hailian Xiao, Tianwen Gao, Duc M. Duong, Michael W. Pennington, James J. Lah, Nicholas T. Seyfried & Allan I. Levey. (2018) Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Xiao-Lu Yuan, Yi-Peng Zhao, Jie Huang, Jun-Chen Liu, Wen-Qian Mao, Jun Yin, Bi-Wen Peng, Wan-Hong Liu, Song Han & Xiao-Hua He. (2018) A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis. CNS Neuroscience & Therapeutics 24:10, pages 967-977.
Crossref
Crossref
Li Ding, Jinbo Hao, Xudong Luo, Wen Zhu, Zheng Wu, Yi Qian, Fangfang Hu, Tianli Liu, Xuzhi Ruan, Shan Li, Jian Li & Zongyun Chen. (2018) The Kv1.3 channel-inhibitory toxin BF9 also displays anticoagulant activity via inhibition of factor XIa. Toxicon 152, pages 9-15.
Crossref
Crossref
Iva Bozic, Katarina Tesovic, Danijela Laketa, Marija Adzic, Marija Jakovljevic, Ivana Bjelobaba, Danijela Savic, Nadezda Nedeljkovic, Sanja Pekovic & Irena Lavrnja. (2018) Voltage Gated Potassium Channel Kv1.3 Is Upregulated on Activated Astrocytes in Experimental Autoimmune Encephalomyelitis. Neurochemical Research 43:5, pages 1020-1034.
Crossref
Crossref
Elham Abdollahi, Amir Abbas Momtazi, Thomas P. Johnston & Amirhossein Sahebkar. (2017) Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades?. Journal of Cellular Physiology 233:2, pages 830-848.
Crossref
Crossref
Jie Huang, Song Han, Qi Sun, Yipeng Zhao, Junchen Liu, Xiaolu Yuan, Wenqian Mao, Biwen Peng, Wanhong Liu, Jun Yin & Xiaohua He. (2017) Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis. Cell & Bioscience 7:1.
Crossref
Crossref
Srikant Rangaraju, Syed Ali Raza, Andrea Pennati, Qiudong Deng, Eric B. Dammer, Duc Duong, Michael W. Pennington, Malu G. Tansey, James J. Lah, Ranjita Betarbet, Nicholas T. Seyfried & Allan I. Levey. (2017) A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation. Journal of Neuroinflammation 14:1.
Crossref
Crossref
Raymond S. Norton & K. George Chandy. (2017) Venom-derived peptide inhibitors of voltage-gated potassium channels. Neuropharmacology 127, pages 124-138.
Crossref
Crossref
Eugene Y. Chiang, Tianbo Li, Surinder Jeet, Ivan Peng, Juan Zhang, Wyne P. Lee, Jason DeVoss, Patrick Caplazi, Jun Chen, Søren Warming, David H. Hackos, Susmith Mukund, Christopher M. Koth & Jane L. Grogan. (2017) Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nature Communications 8:1.
Crossref
Crossref
Ramón Martínez-Mármol, Katarzyna Styrczewska, Mireia Pérez-Verdaguer, Albert Vallejo-Gracia, Núria Comes, Alexander Sorkin & Antonio Felipe. (2017) Ubiquitination mediates Kv1.3 endocytosis as a mechanism for protein kinase C-dependent modulation. Scientific Reports 7:1.
Crossref
Crossref
Austin B. Schwartz, Anshika Kapur, Wentao Wang, Zhenbo Huang, Erminia Fardone, Goutam Palui, Hedi Mattoussi & Debra Ann Fadool. (2016) Margatoxin‐bound quantum dots as a novel inhibitor of the voltage‐gated ion channel Kv1.3. Journal of Neurochemistry 140:3, pages 404-420.
Crossref
Crossref
Nóra Legány, Gergely Toldi, Csaba Orbán, Nóra Megyes, Anna Bajnok & Attila Balog. (2016) Calcium influx kinetics, and the features of potassium channels of peripheral lymphocytes in primary Sjögren’s syndrome. Immunobiology 221:11, pages 1266-1272.
Crossref
Crossref
Soohyun Kwon, Frank Bosmans, Quentin Kaas, Olivier Cheneval, Anne C. Conibear, K. Johan Rosengren, Conan K. Wang, Christina I. Schroeder & David J. Craik. (2016) Efficient enzymatic cyclization of an inhibitory cystine knot‐containing peptide. Biotechnology and Bioengineering 113:10, pages 2202-2212.
Crossref
Crossref
Marie-France Martin-Eauclaire, Adriano M.C. Pimenta, Pierre E. Bougis & Maria-Elena De Lima. (2016) Potassium channel blockers from the venom of the Brazilian scorpion Tityus serrulatus ( ). Toxicon 119, pages 253-265.
Crossref
Crossref
Petra Ehling, Patrick Meuth, Paul Eichinger, Alexander M. Herrmann, Stefan Bittner, Matthias Pawlowski, Susann Pankratz, Michael Herty, Thomas Budde & Sven G. Meuth. (2016) Human T cells in silico: Modelling their electrophysiological behaviour in health and disease. Journal of Theoretical Biology 404, pages 236-250.
Crossref
Crossref
Thomas M. Reeves, Patricia A. Trimmer, Beverly S. Colley & Linda L. Phillips. (2016) Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury. Experimental Neurology 283, pages 188-203.
Crossref
Crossref
B. Wu, B. F. Wu, Y. J. Feng, J. Tao & Y. H. Ji. (2016) Mapping the Interaction Anatomy of BmP02 on Kv1.3 Channel. Scientific Reports 6:1.
Crossref
Crossref
Yuta Takahashi, Zhiqian Yu, Mai Sakai & Hiroaki Tomita. (2016) Linking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric Disorders. Frontiers in Cellular Neuroscience 10.
Crossref
Crossref
Steve Peigneur, Yoko Yamaguchi, Chihiro Kawano, Takeru Nose, Selvanayagam Nirthanan, Ponnampalam Gopalakrishnakone, Jan Tytgat & Kazuki Sato. (2016) Active Sites of Spinoxin, a Potassium Channel Scorpion Toxin, Elucidated by Systematic Alanine Scanning. Biochemistry 55:21, pages 2927-2935.
Crossref
Crossref
Ning Zhao, Qian Dong, Cheng Qian, Sen Li, Qiong-Feng Wu, Dan Ding, Jing Li, Bin-Bin Wang, Ke-fang Guo, Jiang-jiao Xie, Xiang Cheng, Yu-Hua Liao & Yi-Mei Du. (2015) Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties. Scientific Reports 5:1.
Crossref
Crossref
Itsuro Kazama, Tsutomu Tamada & Masahiro Tachi. (2015) Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases. Inflammation Research 64:10, pages 753-765.
Crossref
Crossref
Yu‐Ye Zhou, Guo‐Qiang Hou, Song‐Wei He, Zhuo Xiao, Hui‐Juan Xu, Ya‐Tao Qiu, Sheng Jiang, Hui Zheng & Zhi‐Yuan Li. (2015) Psora‐4, a Kv1.3 Blocker, Enhances Differentiation and Maturation in Neural Progenitor Cells. CNS Neuroscience & Therapeutics 21:7, pages 558-567.
Crossref
Crossref
P Bhargava & P A Calabresi. (2015) Novel therapies for memory cells in autoimmune diseases. Clinical and Experimental Immunology 180:3, pages 353-360.
Crossref
Crossref
Itsuro Kazama. (2015) Roles of Lymphocyte Kv1.3-Channels in the Pathogenesis of Renal Diseases and Novel Therapeutic Implications of Targeting the Channels. Mediators of Inflammation 2015, pages 1-12.
Crossref
Crossref
Itsuro Kazama. (2014) Physiological significance of delayed rectifier K+ channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease. The Journal of Physiological Sciences 65:1, pages 25-35.
Crossref
Crossref
Duane Moogk, Ines Pires da Silva, Michelle W Ma, Erica B Friedman, Eleazar Vega-Saenz de Miera, Farbod Darvishian, Patrick Scanlon, Arianne Perez-Garcia, Anna C Pavlick, Nina Bhardwaj, Paul J Christos, Iman Osman & Michelle Krogsgaard. (2014) Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy. Journal of Translational Medicine 12:1.
Crossref
Crossref
Rong Chen & Shin-Ho Chung. (2014) Binding Modes of Two Scorpion Toxins to the Voltage-Gated Potassium Channel Kv1.3 Revealed from Molecular Dynamics. Toxins 6:7, pages 2149-2161.
Crossref
Crossref
Tadashi Katoh. 2014.
1
39
.
Albert Vallejo-Gracia, Joanna Bielanska, Javier Hernández-Losa, Josep Castellví, M Carmen Ruiz-Marcellan, Santiago Ramón y Cajal, Enric Condom, Joan Manils, Concepció Soler, Núria Comes, Joan Carles Ferreres & Antonio Felipe. (2013) Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy. Journal of Leukocyte Biology 94:4, pages 779-789.
Crossref
Crossref
Yi‐Tian Lian, Xiao‐Fang Yang, Zhao‐Hui Wang, Yong Yang, Ying Yang, Yan‐Wen Shu, Long‐Xian Cheng & Kun Liu. (2012) Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities. Phytotherapy Research 27:9, pages 1321-1327.
Crossref
Crossref
Ning Zhao, Qian Dong, Li-Li Du, Xiao-Xing Fu, Yi-Mei Du & Yu-Hua Liao. (2013) Potent Suppression of Kv1.3 Potassium Channel and IL-2 Secretion by Diphenyl Phosphine Oxide-1 in Human T Cells. PLoS ONE 8:5, pages e64629.
Crossref
Crossref
Yong Yang, Yan-Fu Wang, Xiao-Fang Yang, Zhao-Hui Wang, Yi-Tian Lian, Ying Yang, Xiao-Wei Li, Xiang Gao, Jian Chen, Yan-Wen Shu, Long-Xian Cheng, Yu-Hua Liao & Kun Liu. (2013) Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL. Journal of Lipid Research 54:1, pages 34-43.
Crossref
Crossref
Niels Decher, Michael F. Netter & Anne K. Streit. (2012) Putative Impact of RNA Editing on Drug Discovery. Chemical Biology & Drug Design 81:1, pages 13-21.
Crossref
Crossref
Raveendra Anangi, Shyny Koshy, Redwan Huq, Christine Beeton, Woei-Jer Chuang & Glenn F. King. (2012) Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of KV1.3 Channel Blockers. PLoS ONE 7:12, pages e52965.
Crossref
Crossref
Eric J. Tarcha, Victor Chi, Ernesto J. Muñoz-Elías, David Bailey, Luz M. Londono, Sanjeev K. Upadhyay, Kayla Norton, Amy Banks, Indra Tjong, Hai Nguyen, Xueyou Hu, Greg W. Ruppert, Scott E. Boley, Richard Slauter, James Sams, Brian Knapp, Dustin Kentala, Zachary Hansen, Michael W. Pennington, Christine Beeton, K. George Chandy & Shawn P. Iadonato. (2012) Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease. Journal of Pharmacology and Experimental Therapeutics 342:3, pages 642-653.
Crossref
Crossref
Zhi Li, Wan-Hong Liu, Song Han, Bi-Wen Peng, Jun Yin, Ying-Liang Wu, Xiao-Hua He & Wen-Xin Li. (2012) Selective Inhibition of CCR7− Effector Memory T Cell Activation by a Novel Peptide Targeting Kv1.3 Channel in a Rat Experimental Autoimmune Encephalomyelitis Model. Journal of Biological Chemistry 287:35, pages 29479-29494.
Crossref
Crossref
Carlos González, David Baez‐Nieto, Ignacio Valencia, Ingrid Oyarzún, Patricio Rojas, David Naranjo & Ramón Latorre. 2011. Comprehensive Physiology. Comprehensive Physiology
2087
2149
.
Xiao-Fang Yang, Yong Yang, Yi-Tian Lian, Zhao-Hui Wang, Xiao-Wei Li, Long-Xian Cheng, Jin-Ping Liu, Yan-Fu Wang, Xiang Gao, Yu-Hua Liao, Min Wang, Qiu-Tang Zeng & Kun Liu. (2012) The Antibody Targeting the E314 Peptide of Human Kv1.3 Pore Region Serves as a Novel, Potent and Specific Channel Blocker. PLoS ONE 7:4, pages e36379.
Crossref
Crossref
Xueyou Hu, Teresina Laragione, Liang Sun, Shyny Koshy, Karlie R. Jones, Iskander I. Ismailov, Patricia Yotnda, Frank T. Horrigan, Pércio S. Gulko & Christine Beeton. (2012) KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis. Journal of Biological Chemistry 287:6, pages 4014-4022.
Crossref
Crossref
Li-Hua Wang, Ning Wang, Xiao-Yu Lu, Bing-Chen Liu, Murali K. Yanda, John Z. Song, Helena M. Dai, Yu-Liang Sun, Hui-Fang Bao, Douglas C. Eaton & He-Ping Ma. (2012) Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823:2, pages 505-513.
Crossref
Crossref
Petra Ehling, Stefan Bittner, Thomas Budde, Heinz Wiendl & Sven G. Meuth. (2011) Ion channels in autoimmune neurodegeneration. FEBS Letters 585:23, pages 3836-3842.
Crossref
Crossref
Tom Schilling & Claudia Eder. (2011) Amyloid-β-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia. Journal of Cellular Physiology 226:12, pages 3295-3302.
Crossref
Crossref
Gergely Toldi, András Folyovich, Zsuzsa Simon, Katalin Zsiga, Ambrus Kaposi, Gergő Mészáros, Tivadar Tulassay & Barna Vásárhelyi. (2011) Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon beta. Journal of Neuroimmunology 237:1-2, pages 80-86.
Crossref
Crossref
Alex Cheong, Jing Li, Piruthivi Sukumar, Bhaskar Kumar, Fanning Zeng, Kirsten Riches, Christopher Munsch, Ian C. Wood, Karen E. Porter & David J. Beech. (2011) Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovascular Research 89:2, pages 282-289.
Crossref
Crossref
Soo Hwa JangPan Dong RyuSo Yeong Lee. (2011) Dendrotoxin-κ suppresses tumor growth induced by human lung adenocarcinoma A549 cells in nude mice. Journal of Veterinary Science 12:1, pages 35.
Crossref
Crossref
Supa Hannongbua, Witcha Treesuwan & Warabhorn Boonyarat. 2011. Ion Channels and Their Inhibitors. Ion Channels and Their Inhibitors
53
78
.
Jian Ma, Christie‐Ann McCarl, Sara Khalil, Kevin Lüthy & Stefan Feske. (2010) T‐cell‐specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells. European Journal of Immunology 40:11, pages 3028-3042.
Crossref
Crossref
Claudia Eder. (2010) Ion channels in monocytes and microglia / brain macrophages: Promising therapeutic targets for neurological diseases. Journal of Neuroimmunology 224:1-2, pages 51-55.
Crossref
Crossref
Russell W Teichert & Baldomero M Olivera. (2010) Natural products and ion channel pharmacology. Future Medicinal Chemistry 2:5, pages 731-744.
Crossref
Crossref
Conor McCloskey, Sarah Jones, Stefan Amisten, Roger T. Snowden, Leonard K. Kaczmarek, David Erlinge, Alison H. Goodall, Ian D. Forsythe & Martyn P. Mahaut-Smith. (2010)
Kv1.3 is the exclusive voltage-gated K
+
channel of platelets and megakaryocytes: roles in membrane potential, Ca
2+
signalling and platelet count
. The Journal of Physiology 588:9, pages 1399-1406.
Crossref
Crossref